Effect of Canagliflozin on Blood Pressure and Adverse Events Related to Osmotic Diuresis and Reduced Intravascular Volume in Patients With Type 2 Diabetes Mellitus

The effects of canagliflozin, a sodium glucose co‐transporter 2 inhibitor, on blood pressure (BP) and osmotic diuresis– and intravascular volume reduction–related adverse events (AEs) were evaluated using pooled data from four placebo‐controlled, phase 3 studies in patients with type 2 diabetes mell...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Clin Hypertens (Greenwich)
Hlavní autoři: Weir, Matthew R., Januszewicz, Andrzej, Gilbert, Richard E., Vijapurkar, Ujjwala, Kline, Irina, Fung, Albert, Meininger, Gary
Médium: Artigo
Jazyk:Inglês
Vydáno: John Wiley and Sons Inc. 2014
Témata:
Original Papers
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC8031563/
https://ncbi.nlm.nih.gov/pubmed/25329038
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jch.12425
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky